Book chapter · 2013

Next Generation Drugs in Alzheimer's Disease Treatment: From Benchtop to Bedside

BENTHAM SCIENCE PUBLISHERS eBooks, 109–146 · Published 12 September 2013 · DOI 10.2174/9781608057221113010005

View at the publisherCite this paper

In brief

“Next Generation Drugs in Alzheimer's Disease Treatment: From Benchtop to Bedside” is a 2013 book chapter, published in BENTHAM SCIENCE PUBLISHERS eBooks. OpenAlex counts 0 citations as of 15 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0

Abstract

Alzheimer’s disease (AD), the most common cause of dementia in the elderly, is a neurodegenerative disorder characterized by severe and progressive cognitive impairment, including impaired decision making and orientation, inability to perform activities of daily living, language impairment and psycho-behavioural disturbances. Molecular studies based on interdisciplinary approaches, including biochemical investigations, immunohistochemistry, molecular and cell biology… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Next Generation Drugs in Alzheimer's Disease Treatment: From Benchtop to Bedside. (2013). BENTHAM SCIENCE PUBLISHERS eBooks, 109–146. https://doi.org/10.2174/9781608057221113010005

MLA 9

“Next Generation Drugs in Alzheimer's Disease Treatment: From Benchtop to Bedside.” BENTHAM SCIENCE PUBLISHERS eBooks, 2013, pp. 109–146. https://doi.org/10.2174/9781608057221113010005.

Chicago

2013. “Next Generation Drugs in Alzheimer's Disease Treatment: From Benchtop to Bedside.” BENTHAM SCIENCE PUBLISHERS eBooks: 109–146. https://doi.org/10.2174/9781608057221113010005.

Harvard

(2013) ‘Next Generation Drugs in Alzheimer's Disease Treatment: From Benchtop to Bedside’, BENTHAM SCIENCE PUBLISHERS eBooks, pp. 109–146. doi:10.2174/9781608057221113010005.

IEEE

“Next Generation Drugs in Alzheimer's Disease Treatment: From Benchtop to Bedside,” BENTHAM SCIENCE PUBLISHERS eBooks, pp. 109–146, 2013, doi: 10.2174/9781608057221113010005.

BibTeX

@incollection{anon2013next,
  title     = {{Next Generation Drugs in Alzheimer's Disease Treatment: From Benchtop to Bedside}},
  booktitle = {BENTHAM SCIENCE PUBLISHERS eBooks},
  publisher = {Bentham Science Publishers},
  year      = {2013},
  pages     = {109--146},
  doi       = {10.2174/9781608057221113010005},
  url       = {https://doi.org/10.2174/9781608057221113010005}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments

  • Alzheimer's disease
  • disease-modifying drugs
  • amyloid plaques
  • neurofibrillary tangles
  • cholinesterase inhibitors
  • NMDA receptor antagonists
  • biomarkers
  • preclinical diagnosis

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Next Generation Drugs in Alzheimer's Disease Treatment: From Benchtop to Bedside. (2013). BENTHAM SCIENCE PUBLISHERS eBooks, 109–146. https://doi.org/10.2174/9781608057221113010005

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

What is the DOI of this paper?

10.2174/9781608057221113010005. The permanent link is https://doi.org/10.2174/9781608057221113010005.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.